(6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)acetic acid, 95.0%, 5g

5,6-Dihydro-4H-pyrrolo[1,2-b]pyrazole-2-carboxylic acid, 95.0%, 100g

2-[(4-Chlorophenyl)sulfonyl]-N'-hydroxyethanimid-amide, 98.0%, 1g

Weighing paper ROTILABO®, 102 mm, 102 mm, 500 Piece(s)

N-[[1,1'-Biphenyl]-4-yl]-9,9-dimethyl-N-[4-(9-phenyl-9H-carbazol-3-yl)phenyl]-9H-fluoren-2-amine>98.0%(HPLC)(N)5g

2-Bromo-4-(tert-butyl)-1-methoxybenzene, 95.0%, 250mg

1-Bromo-2,4,5-trimethylbenzene, 95.0%, 10g

N-methyl-1-(3-methyl-1,2,4-oxadiazol-5-yl)methanamine hydrochloride, 95.0%, 1g

4-((6-Chloro-3-(4-chloro-2-fluorobenzyl)-2-methylimidazo[1,2-b]pyridazin-8-yl)methyl)morpholine, 98%, 250mg

6-Bromomethyl-nicotinic acid ethyl ester, 95.0%, 100mg

4-Bromocinnamic acid, 98.0%, 10g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 200, 10000 ml, 250 mm, 1 Piece

1-Ethyl-3-methyl-9H-pyrido[3,4-b]indole, 97%, 100mg